Expertise in
24
conditions

Dr. Sunil Singhal

Thoracic Surgery
51 N. 39th Street, Pavilion For Advanced Care, First Floor, 
Philadelphia, PA 
On Staff At
Accepting New Patients
Offers Telehealth
Expertise in
24
conditions
51 N. 39th Street, Pavilion For Advanced Care, First Floor, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sunil Singhal is a Thoracic Surgeon in Philadelphia, Pennsylvania. Dr. Singhal is rated as an Experienced provider by MediFind in the treatment of Pectus Carinatum. His top areas of expertise are Lung Nodules, Lung Cancer, Mesothelioma, Thymectomy, and Pancreaticoduodenectomy. Dr. Singhal is currently accepting new patients.

His clinical research consists of co-authoring 266 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Pennsylvania School Of Medicine
Residency
Johns Hopkins Hospital
Specialties
Thoracic Surgery
Licenses
Thoracic Surgery (Cardiothoracic Vascular Surgery) in PA
Board Certifications
Surgery, 2014
Thoracic And Cardiac Surgery, 2009
Fellowships
Hospital of the University of Pennsylvania
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Chester County Hospital
Pennsylvania Hospital
Penn Presbyterian Medical Center
Languages Spoken
English
Gender
Male
Awards
Recognized annually in Philadelphia magazine's Top Docs issue from 2018 through 2025

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Penn Mesothelioma and Pleural Program
51 N. 39th Street, Pavilion For Advanced Care, First Floor, Philadelphia, PA 19104
Other Locations
Penn Thoracic Surgery Perelman
3400 Civic Center Boulevard, West Pavilion, 4th Floor, Philadelphia, PA 19104
Penn Thoracic Surgery Washington Square
800 Walnut Street, 20th Floor, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Singhal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Esophageal Cancer
Lung Cancer
Pectus Carinatum
Diaphragmatic Hernia
Pleural Effusion
Mesothelioma
Pectus Excavatum

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer
Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 11, 2025
Intervention Type: Biological
Study Drug: AdV-tk (Aglatimagene Besadenovec)+Valacyclovir
Study Phase: Phase 1
A Phase 2, Single-Dose, Open-Label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies, in Patients Undergoing Routine Surgery
A Phase 2, Single-Dose, Open-Label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies, in Patients Undergoing Routine Surgery
Enrollment Status: Completed
Publish Date: November 08, 2024
Intervention Type: Drug, Procedure
Study Phase: Phase 2
A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Enrollment Status: Completed
Publish Date: March 24, 2023
Intervention Type: Drug, Procedure, Device
Study Phase: Phase 2
A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Enrollment Status: Completed
Publish Date: March 23, 2023
Intervention Type: Drug, Device
Study Drug: OTL38
Study Phase: Phase 3
Intraoperative Imaging of Pulmonary Nodules by OTL38
Intraoperative Imaging of Pulmonary Nodules by OTL38
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Drug: OTL38
Study Phase: Phase 1
Optional Sub-study to Intraoperative Imaging With ICG Registry
Optional Sub-study to Intraoperative Imaging With ICG Registry
Enrollment Status: Completed
Publish Date: June 24, 2021
Intervention Type: Other
Intraoperative Imaging With ICG Registry
Intraoperative Imaging With ICG Registry
Enrollment Status: Completed
Publish Date: June 24, 2021
Intervention Type: Other
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Optional Sub-Study I: ICG Optional Sub-Study II: OTL38
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Optional Sub-Study I: ICG Optional Sub-Study II: OTL38
Enrollment Status: Completed
Publish Date: June 18, 2021
Intervention Type: Drug
A Phase 0/1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subject Undergoing Breast Cancer Surgery
A Phase 0/1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subject Undergoing Breast Cancer Surgery
Enrollment Status: Completed
Publish Date: January 28, 2021
Intervention Type: Drug
Study Phase: Early Phase 1
A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma
A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma
Enrollment Status: Terminated
Publish Date: August 06, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Parathyroidectomy for Primary Hyperparathyroidism.
A Pilot & Feasibility Study of the Imaging Potential of EC17 in Subjects Undergoing Parathyroidectomy for Primary Hyperparathyroidism.
Enrollment Status: Completed
Publish Date: July 03, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Pilot and Feasibility Study of Intraoperative Imagery of Solid Tumors With Indocyanine Green
A Pilot and Feasibility Study of Intraoperative Imagery of Solid Tumors With Indocyanine Green
Enrollment Status: Completed
Publish Date: March 20, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Pilot & Feasibility Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Minimally Invasive Thoracic Surgery Presenting With Thoracic Nodules
A Pilot & Feasibility Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Minimally Invasive Thoracic Surgery Presenting With Thoracic Nodules
Enrollment Status: Completed
Publish Date: March 20, 2018
Intervention Type: Drug
Study Phase: Phase 1
Intraoperative Imaging of Pulmonary Adenocarcinoma
Intraoperative Imaging of Pulmonary Adenocarcinoma
Enrollment Status: Withdrawn
Publish Date: March 02, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Thoracic Surgery Presenting With Lung Nodules
A Phase 1, Open-Label, Single Center Study of the Imaging Potential of Indocyanine Green in Subjects Undergoing Thoracic Surgery Presenting With Lung Nodules
Enrollment Status: Completed
Publish Date: February 05, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 14 Less Clinical Trials

266 Total Publications

Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma.
Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma.
Journal: Cancers
Published: September 30, 2025
Similar Doctors
Vakhtang Tchantchaleishvili
Experienced in Pectus Carinatum
Dr. Vakhtang Tchantchaleishvili
Thoracic Surgery | General Surgery
Experienced in Pectus Carinatum
Dr. Vakhtang Tchantchaleishvili
Thoracic Surgery | General Surgery

Jefferson Cardiac Surgery - Honickman Center

1101 Chestnut Street, Floor 9, 
Philadelphia, PA 
 (1.8 miles away)
215-955-6996
Languages Spoken:
English, Georgian, German, Russian
See accepted insurances
Accepting New Patients

Vakhtang Tchantchaleishvili is a General Surgeon and a Thoracic Surgeon in Philadelphia, Pennsylvania. Dr. Tchantchaleishvili is rated as a Distinguished provider by MediFind in the treatment of Pectus Carinatum. His top areas of expertise are Aortic Valve Stenosis, Cardiogenic Shock, Hemolysis, Heart Transplant, and Heart Bypass Surgery. Dr. Tchantchaleishvili is currently accepting new patients.

Experienced in Pectus Carinatum
Dr. Claude Beaty
Thoracic Surgery
Experienced in Pectus Carinatum
Dr. Claude Beaty
Thoracic Surgery

Nemours Children's Hospital Delaware

1600 Rockland Rd, 
Wilmington, DE 
 (22.4 miles away)
302-651-4200
Languages Spoken:
English
See accepted insurances

Claude Beaty is a Thoracic Surgeon in Wilmington, Delaware. Dr. Beaty is rated as an Advanced provider by MediFind in the treatment of Pectus Carinatum. His top areas of expertise are Mitral Atresia, Double Aortic Arch, Vascular Ring, Patent Ductus Arteriosus, and Heart Transplant.

Experienced in Pectus Carinatum
Dr. Jeremy Herrmann
Thoracic Surgery
Experienced in Pectus Carinatum
Dr. Jeremy Herrmann
Thoracic Surgery

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-590-2709
Languages Spoken:
English
See accepted insurances

Jeremy Herrmann is a Thoracic Surgeon in Philadelphia, Pennsylvania. Dr. Herrmann is rated as an Advanced provider by MediFind in the treatment of Pectus Carinatum. His top areas of expertise are Truncus Arteriosus, Total Anomalous Pulmonary Venous Return, Hypoplastic Left Heart Syndrome (HLHS), Aneurysm Repair, and Patent Foramen Ovale Repair.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singhal's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 10 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile